Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
654,478
-
Share change
-
+85,114
-
Total reported value
-
$1,498,000
-
Price per share
-
$2.29
-
Number of holders
-
11
-
Value change
-
+$194,457
-
Number of buys
-
4
-
Number of sells
-
3
Institutional Holders of HCW Biologics Inc. - COM (HCWB) as of Q3 2022
As of 30 Sep 2022,
HCW Biologics Inc. - COM (HCWB) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
654,478 shares.
The largest 10 holders included
HighTower Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, BlackRock Inc., TWO SIGMA INVESTMENTS, LP, STATE STREET CORP, Cresset Asset Management, LLC, Tower Research Capital LLC (TRC), and MORGAN STANLEY.
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.